{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:43:00Z","timestamp":1793828580407,"version":"4.6.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangxi Province Key Laboratory of Molecular Medicine","award":["No.2024SSY06231"],"award-info":[{"award-number":["No.2024SSY06231"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82160162"],"award-info":[{"award-number":["No.82160162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Research, Development Program of Jiangxi Province","award":["20243BBI91008"],"award-info":[{"award-number":["20243BBI91008"]}]},{"name":"Project of the Second Affiliated Hospital of Nanchang University","award":["2022efyA04"],"award-info":[{"award-number":["2022efyA04"]}],"id":[{"id":"https:\/\/ror.org\/01nxv5c88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02873-8","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:00:37Z","timestamp":1753909237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiajun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin\u2019e","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"2873_CR1","doi-asserted-by":"crossref","unstructured":"Tan S, Zheng BB, Tang ML, Chu H, Zhao YT, Weng C. Global burden of cardiovascular diseases and its risk factors, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Qjm-Int J Med. 2025.","DOI":"10.1093\/qjmed\/hcaf022"},{"key":"2873_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Bhutta ZA. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"2873_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","volume":"74","author":"GA Mensah","year":"2019","unstructured":"Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74:2529\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"2873_CR4","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"2873_CR5","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action. J Am Coll Cardiol. 2020;76:2980\u20131.","journal-title":"J Am Coll Cardiol"},{"key":"2873_CR6","doi-asserted-by":"publisher","first-page":"H1218","DOI":"10.1152\/ajpheart.00826.2024","volume":"328","author":"WB Horton","year":"2025","unstructured":"Horton WB, Love KM, Gregory JM, Liu Z, Barrett EJ. Metabolic and vascular insulin resistance: partners in the pathogenesis of cardiovascular disease in diabetes. Am J Physiol-Heart C. 2025;328:H1218\u201336.","journal-title":"Am J Physiol-Heart C"},{"key":"2873_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12933-024-02510-w","volume":"23","author":"X Tian","year":"2024","unstructured":"Tian X, Chen S, Xia X, Xu Q, Zhang Y, Zheng C, et al. Pathways from insulin resistance to incident cardiovascular disease: a Bayesian network analysis. Cardiovasc Diabetol. 2024;23:421.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","volume":"19","author":"J Alizargar","year":"2020","unstructured":"Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19:8.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12944-024-02412-6","volume":"23","author":"V Gounden","year":"2024","unstructured":"Gounden V, Devaraj S, Jialal I. The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024;23:416.","journal-title":"Lipids Health Dis"},{"key":"2873_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02674-z","volume":"24","author":"J Qiu","year":"2025","unstructured":"Qiu J, Li J, Xu S, Zeng H, Zhang Y, Yang S, et al. Can cardiovascular health and its modifiable healthy lifestyle offset the increased risk of all-cause and cardiovascular deaths associated with insulin resistance? Cardiovasc Diabetol. 2025;24: 114.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR11","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.ajpc.2025.100996","volume":"22","author":"I Dakota","year":"2025","unstructured":"Dakota I, Huang W, Wijayanto MA, Nurhafizah A, Khairunnisa AR, Rachmayanti S, et al. Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: a systematic review and meta-analysis. Am J Prev Cardiol. 2025;22:100996.","journal-title":"Am J Prev Cardiol"},{"key":"2873_CR12","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1186\/s12889-025-22901-2","volume":"25","author":"T Yi","year":"2025","unstructured":"Yi T, Lin Z, Hu F, Chen J, Chen L. Impact of the triglyceride-glucose index on all-cause and cardiovascular mortalities across different metabolic health and obesity statuses in US adults. BMC Public Health. 2025;25:1767.","journal-title":"BMC Public Health"},{"key":"2873_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12933-025-02758-w","volume":"24","author":"X Gao","year":"2025","unstructured":"Gao X, Chen T, Zhou F, Sun Y, Zhang J, Li X, et al. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2025;24:200.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR14","doi-asserted-by":"crossref","unstructured":"Ruan H, Duan S, He L, Wang Y, Yao Z, Pan L, et al. The incremental prognostic value of incorporating the triglyceride-glucose index into the traditional cardiovascular risk factors for the long-term prognosis in ischemic cardiomyopathy patients with HFpEF following coronary artery bypass grafting: a multicenter cohort study. J Atheroscler Thromb. 2025.","DOI":"10.5551\/jat.65654"},{"key":"2873_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41574-025-01097-w","volume":"21","author":"O Tysoe","year":"2025","unstructured":"Tysoe O. Obesity induces systemic insulin resistance via endothelium-specific insulin receptor inhibition. Nat Rev Endocrinol. 2025;21:199.","journal-title":"Nat Rev Endocrinol"},{"key":"2873_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.mcna.2011.06.002","volume":"95","author":"GM Reaven","year":"2011","unstructured":"Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin N Am. 2011;95:875\u201392.","journal-title":"Med Clin N Am"},{"key":"2873_CR17","doi-asserted-by":"publisher","first-page":"1515559","DOI":"10.3389\/fendo.2025.1515559","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Tan L. Association of insulin resistance-related indicators with cardiovascular disease in Chinese people with different glycemic states. Front Endocrinol. 2025;16:1515559.","journal-title":"Front Endocrinol"},{"key":"2873_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13098-025-01616-9","volume":"17","author":"RM Rabiee","year":"2025","unstructured":"Rabiee RM, Ghasempour DG, Sadri H, Darouei B, Amani-Beni R, Mazaheri-Tehrani S. Triglyceride glucose-waist circumference as a predictor of mortality and subtypes of cardiovascular disease: a systematic review and meta-analysis. Diabetol Metab Syndr. 2025;17:59.","journal-title":"Diabetol Metab Syndr"},{"key":"2873_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-025-02591-1","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, Zhang Z, Luo X, Xiao Y, Tu T, Liu C, et al. The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis. Cardiovasc Diabetol. 2025;24:47.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR20","doi-asserted-by":"publisher","first-page":"1471535","DOI":"10.3389\/fendo.2024.1471535","volume":"15","author":"D Zheng","year":"2024","unstructured":"Zheng D, Cai J, Xu S, Jiang S, Li C, Wang B. The association of triglyceride-glucose index and combined obesity indicators with chest pain and risk of cardiovascular disease in American population with prediabetes or diabetes. Front Endocrinol. 2024;15:1471535.","journal-title":"Front Endocrinol"},{"key":"2873_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12933-024-02306-y","volume":"23","author":"SR Mirjalili","year":"2024","unstructured":"Mirjalili SR, Soltani S, Meybodi ZH, Marques-Vidal P, Firouzabadi DD, Eshraghi R, et al. Which surrogate insulin resistance indices best predict coronary artery disease? A machine learning approach. Cardiovasc Diabetol. 2024;23:214.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12933-024-02290-3","volume":"23","author":"X Xia","year":"2024","unstructured":"Xia X, Chen S, Tian X, Xu Q, Zhang Y, Zhang X, et al. Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort. Cardiovasc Diabetol. 2024;23:208.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12933-024-02281-4","volume":"23","author":"X Zhu","year":"2024","unstructured":"Zhu X, Xu W, Song T, Wang X, Wang Q, Li J, et al. Changes in the combination of the triglyceride-glucose index and obesity indicators estimate the risk of cardiovascular disease. Cardiovasc Diabetol. 2024;23:192.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-024-02278-z","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Qi Y, Song J, Shang X, Han T, Han N, et al. Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults. Cardiovasc Diabetol. 2024;23:185.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13098-024-01340-w","volume":"16","author":"Y Zhuang","year":"2024","unstructured":"Zhuang Y, Qiu L, Han D, Qiao Z, Wang F, Jiang Q, et al. The association between triglyceride-glucose index and related parameters and risk of cardiovascular disease in American adults under different glucose metabolic states. Diabetol Metab Syndr. 2024;16:102.","journal-title":"Diabetol Metab Syndr"},{"key":"2873_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23:8.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR27","doi-asserted-by":"publisher","first-page":"1290226","DOI":"10.3389\/fendo.2024.1290226","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu L, Peng J, Wang N, Wu Z, Zhang Y, Cui H, et al. Comparison of seven surrogate insulin resistance indices for prediction of incident coronary heart disease risk: a 10-year prospective cohort study. Front Endocrinol. 2024;15:1290226.","journal-title":"Front Endocrinol"},{"key":"2873_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24:52.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24:12.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-025-02576-0","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tu Z, Liu S, Wang J, Shi J, Li X, et al. Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity. Cardiovasc Diabetol. 2025;24:33.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12933-025-02604-z","volume":"24","author":"HM He","year":"2025","unstructured":"He HM, Xie YY, Chen Q, Li YK, Li XX, Fu SJ, et al. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc Diabetol. 2025;24:69.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2873_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pcad.2018.07.003","volume":"61","author":"A Elagizi","year":"2018","unstructured":"Elagizi A, Kachur S, Lavie CJ, Carbone S, Pandey A, Ortega FB, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61(2):142\u201350.","journal-title":"Prog Cardiovasc Dis"},{"key":"2873_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pcad.2018.06.004","volume":"61","author":"ME Pich\u00e9","year":"2018","unstructured":"Pich\u00e9 ME, Poirier P, Lemieux I, Despr\u00e9s JP. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update. Prog Cardiovasc Dis. 2018;61:103\u201313.","journal-title":"Prog Cardiovasc Dis"},{"key":"2873_CR34","doi-asserted-by":"publisher","first-page":"E875","DOI":"10.1503\/cmaj.191707","volume":"192","author":"S Wharton","year":"2020","unstructured":"Wharton S, Lau D, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. Can Med Assoc J. 2020;192:E875\u201391.","journal-title":"Can Med Assoc J"},{"issue":"Suppl 2","key":"2873_CR35","first-page":"51S","volume":"6","author":"Clinical Guidelines on the Identification","year":"1998","unstructured":"Clinical Guidelines on the Identification. Evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res. 1998;6(Suppl 2):51S-209S.","journal-title":"Obes Res"},{"key":"2873_CR36","doi-asserted-by":"publisher","first-page":"16753","DOI":"10.1038\/s41598-018-35073-4","volume":"8","author":"Y Park","year":"2018","unstructured":"Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep-Uk. 2018;8:16753.","journal-title":"Sci Rep-Uk"},{"key":"2873_CR37","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1111\/dom.15929","volume":"26","author":"TY Zhang","year":"2024","unstructured":"Zhang TY, Zhang ZM, Wang XN, Kuang HY, Xu Q, Li HX, et al. Relationship between weight-adjusted-waist index and all-cause and cardiovascular mortality in individuals with type 2 diabetes. Diabetes Obes Metab. 2024;26:5621\u20139.","journal-title":"Diabetes Obes Metab"},{"key":"2873_CR38","doi-asserted-by":"publisher","first-page":"1457869","DOI":"10.3389\/fendo.2024.1457869","volume":"15","author":"W Liu","year":"2024","unstructured":"Liu W, Yang X, Zhan T, Huang M, Tian X, Tian X, et al. Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999\u20132018. Front Endocrinol. 2024;15:1457869.","journal-title":"Front Endocrinol"},{"key":"2873_CR39","doi-asserted-by":"publisher","first-page":"24061","DOI":"10.1038\/s41598-024-74339-y","volume":"14","author":"P Zhao","year":"2024","unstructured":"Zhao P, Du T, Zhou Q, Wang Y. Association of weight-adjusted-waist index with all-cause and cardiovascular mortality in individuals with diabetes or prediabetes: a cohort study from NHANES 2005\u20132018. Sci Rep-Uk. 2024;14:24061.","journal-title":"Sci Rep-Uk"},{"key":"2873_CR40","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.clinsp.2023.100248","volume":"78","author":"Y Han","year":"2023","unstructured":"Han Y, Shi J, Gao P, Zhang L, Niu X, Fu N. The weight-adjusted-waist index predicts all-cause and cardiovascular mortality in general US adults. Clinics. 2023;78:100248.","journal-title":"Clinics"},{"key":"2873_CR41","doi-asserted-by":"publisher","first-page":"1501551","DOI":"10.3389\/fcvm.2025.1501551","volume":"12","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Nie Z, Zhang Y, Sun T. The weight-adjusted-waist index predicts all-cause and cardiovascular mortality in hypertension. Front Cardiovasc Med. 2025;12:1501551.","journal-title":"Front Cardiovasc Med"},{"key":"2873_CR42","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.numecd.2022.01.033","volume":"32","author":"C Ding","year":"2022","unstructured":"Ding C, Shi Y, Li J, Li M, Hu L, Rao J, et al. Association of weight-adjusted-waist index with all-cause and cardiovascular mortality in China: a prospective cohort study. Nutr Metab Cardiovas. 2022;32:1210\u20137.","journal-title":"Nutr Metab Cardiovas"},{"issue":"1","key":"2873_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13690-024-01451-w","volume":"82","author":"S Sadafi","year":"2024","unstructured":"Sadafi S, Azizi A, Shakiba E, Pasdar Y. Weight-adjusted waist index and cardiovascular disease: a population-based study in Ravansar, Iran. Arch Public Health. 2024;82(1):219.","journal-title":"Arch Public Health"},{"key":"2873_CR44","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.1038\/s41598-025-99618-0","volume":"15","author":"G Huo","year":"2025","unstructured":"Huo G, Tan Z, Tang Y, Huang J, Cao J, Zhou D. Association between triglyceride glucose weight adjusted waist index and stroke risk in different glucose metabolism status. Sci Rep-Uk. 2025;15:15813.","journal-title":"Sci Rep-Uk"},{"key":"2873_CR45","unstructured":"National Health and Nutrition Examination Survey (NHANES) website. (https:\/\/www.cdc.gov\/nchs\/nhanes\/about\/index.html)"},{"key":"2873_CR46","unstructured":"National Centre for Health Statistics (NCHS) website. (https:\/\/www.cdc.gov\/nchs\/data-linkage\/mortality-public.htm)."},{"key":"2873_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-025-02742-4","volume":"24","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24:183.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR48","doi-asserted-by":"publisher","first-page":"1382419","DOI":"10.3389\/fendo.2024.1382419","volume":"15","author":"GH Pan","year":"2024","unstructured":"Pan GH, Zhang JQ, Sun YY, Shi YH, Zhang FR. Saturation association between serum 25-hydroxyvitamin D levels and mortality in elderly people with hyperlipidemia: a population-based study from the NHANES (2001\u20132016). Front Endocrinol. 2024;15:1382419.","journal-title":"Front Endocrinol"},{"key":"2873_CR49","doi-asserted-by":"publisher","first-page":"e2415051","DOI":"10.1001\/jamanetworkopen.2024.15051","volume":"7","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma N, Lin Q, Chen K, Zheng F, Wu J, et al. Body roundness index and all-cause mortality among US adults. JAMA Netw Open. 2024;7:e2415051.","journal-title":"JAMA Netw Open"},{"key":"2873_CR50","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","volume":"14","author":"T Sato","year":"2003","unstructured":"Sato T, Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology. 2003;14:680\u20136.","journal-title":"Epidemiology"},{"key":"2873_CR51","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.2147\/DMSO.S462181","volume":"17","author":"J Qiu","year":"2024","unstructured":"Qiu J, Huang X, Kuang M, Yang R, Li J, Sheng G, et al. Lipoprotein combine index as a better marker for NAFLD identification than traditional lipid parameters. Diabet Metab Synd Ob. 2024;17:2583\u201395.","journal-title":"Diabet Metab Synd Ob"},{"issue":"110","key":"2873_CR52","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/jnci\/djx286","volume":"I","author":"D Yu","year":"2018","unstructured":"Yu D, Zheng W, Johansson M, Lan Q, Park Y, White E, et al. Overall and central obesity and risk of lung cancer: a pooled analysis. J Natl Cancer. 2018;I(110):831\u201342.","journal-title":"J Natl Cancer"},{"key":"2873_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D\u2019Agostino RS, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11\u201321.","journal-title":"Stat Med"},{"key":"2873_CR54","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","volume":"357","author":"R Wang","year":"2007","unstructured":"Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine\u2013reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189\u201394.","journal-title":"N Engl J Med"},{"key":"2873_CR55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ Van der Weele","year":"2017","unstructured":"Van der Weele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268\u201374.","journal-title":"Ann Intern Med"},{"key":"2873_CR56","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, et al. Association between triglyceride-glucose related indices and mortality among individuals with nonalcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23:232.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23:134.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24:92.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR59","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23:188.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR60","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12933-024-02390-0","volume":"23","author":"S Li","year":"2024","unstructured":"Li S, An L, Fu Z, Zhang W, Liu H. Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study. Cardiovasc Diabetol. 2024;23:286.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR61","doi-asserted-by":"publisher","first-page":"e13430","DOI":"10.1111\/apha.13430","volume":"228","author":"M Makrecka-Kuka","year":"2020","unstructured":"Makrecka-Kuka M, Liepinsh E, Murray AJ, Lemieux H, Dambrova M, Tepp K, et al. Altered mitochondrial metabolism in the insulin-resistant heart. Acta Physiol. 2020;228:e13430.","journal-title":"Acta Physiol"},{"key":"2873_CR62","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1113\/JP279376","volume":"599","author":"M Federico","year":"2021","unstructured":"Federico M, De la Fuente S, Palomeque J, Sheu SS. The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction. J Physiol. 2021;599:3477\u201393.","journal-title":"J Physiol"},{"key":"2873_CR63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","volume":"102","author":"JA Kim","year":"2008","unstructured":"Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102:401\u201314.","journal-title":"Circ Res"},{"key":"2873_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00424-021-02638-8","volume":"474","author":"HN de Las","year":"2022","unstructured":"de Las HN, Lahera V. Relevance of mitochondrial dysfunction in heart disease associated with insulin resistance conditions. Pflug Arch Eur J Phy. 2022;474:21\u201331.","journal-title":"Pflug Arch Eur J Phy"},{"key":"2873_CR65","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2337\/dc09-0749","volume":"33","author":"M Laakso","year":"2010","unstructured":"Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33:442\u20139.","journal-title":"Diabetes Care"},{"key":"2873_CR66","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/ijms25052973","volume":"25","author":"G Gallo","year":"2024","unstructured":"Gallo G, Savoia C. New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications. Int J Mol Sci. 2024;25:2973.","journal-title":"Int J Mol Sci"},{"key":"2873_CR67","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/aps.2010.95","volume":"31","author":"R Li","year":"2010","unstructured":"Li R, Lau WB, Ma XL. Adiponectin resistance and vascular dysfunction in the hyperlipidemic state. Acta Pharmacol Sin. 2010;31:1258\u201366.","journal-title":"Acta Pharmacol Sin"},{"key":"2873_CR68","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00109-010-0663-9","volume":"88","author":"J Ren","year":"2010","unstructured":"Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med. 2010;88:993\u20131001.","journal-title":"J Mol Med"},{"key":"2873_CR69","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.tem.2011.05.001","volume":"22","author":"S Gray","year":"2011","unstructured":"Gray S, Kim JK. New insights into insulin resistance in the diabetic heart. Trends Endocrin Met. 2011;22:394\u2013403.","journal-title":"Trends Endocrin Met"},{"key":"2873_CR70","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GN, Kitsis RN, et al. Mitochondrial function, biology, and role in disease: a scientific statement from the American Heart Association. Circ Res. 2016;118:1960\u201391.","journal-title":"Circ Res"},{"key":"2873_CR71","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","volume":"1863","author":"JS Bhatti","year":"2017","unstructured":"Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders-a step toward mitochondria based therapeutic strategies. Biochim et Biophys Acta (BBA) Mol Basis Dis. 2017;1863:1066\u201377.","journal-title":"Biochim et Biophys Acta (BBA) Mol Basis Dis."},{"key":"2873_CR72","doi-asserted-by":"publisher","first-page":"154502","DOI":"10.1016\/j.phymed.2022.154502","volume":"108","author":"X Chang","year":"2023","unstructured":"Chang X, Li Y, Liu J, Wang Y, Guan X, Wu Q, et al. \u00df-tubulin contributes to Tongyang Huoxue decoction-induced protection against hypoxia\/reoxygenation-induced injury of sinoatrial node cells through SIRT1-mediated regulation of mitochondrial quality surveillance. Phytomedicine. 2023;108:154502.","journal-title":"Phytomedicine"},{"key":"2873_CR73","doi-asserted-by":"publisher","first-page":"117371","DOI":"10.1016\/j.jep.2023.117371","volume":"320","author":"X Chang","year":"2024","unstructured":"Chang X, Zhou S, Liu J, Wang Y, Guan X, Wu Q, et al. Zishen tongyang huoxue decoction (TYHX) alleviates sinoatrial node cell ischemia\/reperfusion injury by directing mitochondrial quality control via the VDAC1-\u03b2-tubulin signaling axis. J Ethnopharmacol. 2024;320:117371.","journal-title":"J Ethnopharmacol"},{"key":"2873_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Yu J, Li R, Zhou H, Chang X. New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation. Cell Mol Biol Lett. 2024;29:21.","journal-title":"Cell Mol Biol Lett"},{"key":"2873_CR75","doi-asserted-by":"publisher","first-page":"155331","DOI":"10.1016\/j.phymed.2023.155331","volume":"132","author":"X Chang","year":"2024","unstructured":"Chang X, Zhou S, Liu J, Wang Y, Guan X, Wu Q, et al. Zishenhuoxue decoction-induced myocardial protection against ischemic injury through TMBIM6-VDAC1-mediated regulation of calcium homeostasis and mitochondrial quality surveillance. Phytomedicine. 2024;132:155331.","journal-title":"Phytomedicine"},{"key":"2873_CR76","doi-asserted-by":"publisher","first-page":"734","DOI":"10.18632\/aging.100505","volume":"4","author":"F Pintus","year":"2012","unstructured":"Pintus F, Floris G, Rufini A. Nutrient availability links mitochondria, apoptosis, and obesity. Aging. 2012;4:734\u201341.","journal-title":"Aging"},{"key":"2873_CR77","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2741\/4758","volume":"24","author":"RT Atawia","year":"2019","unstructured":"Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci-Landmrk. 2019;24:890\u2013934.","journal-title":"Front Biosci-Landmrk"},{"key":"2873_CR78","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4093\/dmj.2021.0294","volume":"46","author":"JY Kim","year":"2022","unstructured":"Kim JY, Choi J, Vella CA, Criqui MH, Allison MA, Kim NH. Associations between weight-adjusted waist index and abdominal fat and muscle mass: multi-ethnic study of atherosclerosis. Diabetes Metab J. 2022;46:747\u201355.","journal-title":"Diabetes Metab J"},{"key":"2873_CR79","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7150\/ijbs.76223","volume":"19","author":"X Chang","year":"2023","unstructured":"Chang X, Liu R, Li R, Peng Y, Zhu P, Zhou H. Molecular mechanisms of mitochondrial quality control in ischemic cardiomyopathy. Int J Biol Sci. 2023;19:426\u201348.","journal-title":"Int J Biol Sci"},{"key":"2873_CR80","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00204-023-03599-w","volume":"97","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhou H, Chang X. Involvement of mitochondrial dynamics and mitophagy in diabetic endothelial dysfunction and cardiac microvascular injury. Arch Toxicol. 2023;97:3023\u201335.","journal-title":"Arch Toxicol"},{"key":"2873_CR81","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-55330-6_15","volume":"982","author":"N Torrealba","year":"2017","unstructured":"Torrealba N, Aranguiz P, Alonso C, Rothermel BA, Lavandero S. Mitochondria in structural and functional cardiac remodeling. Adv Exp Med Biol. 2017;982:277\u2013306.","journal-title":"Adv Exp Med Biol"},{"key":"2873_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/biom10010085","author":"H Zhou","year":"2020","unstructured":"Zhou H, Toan S. Pathological roles of mitochondrial oxidative stress and mitochondrial dynamics in cardiac microvascular ischemia\/reperfusion injury. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10010085.","journal-title":"Biomolecules"},{"key":"2873_CR83","doi-asserted-by":"publisher","first-page":"e004174","DOI":"10.1161\/JAHA.116.004174","volume":"6","author":"JR Lewis","year":"2017","unstructured":"Lewis JR, Lim WH, Wong G, Abbs S, Zhu K, Lim EM, et al. Association between high-sensitivity cardiac troponin I and cardiac events in elderly women. J Am Heart Assoc. 2017;6:e004174.","journal-title":"J Am Heart Assoc"},{"key":"2873_CR84","first-page":"1","volume":"68","author":"M Heron","year":"2019","unstructured":"Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68:1\u201377.","journal-title":"Natl Vital Stat Rep"},{"key":"2873_CR85","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.286.2.180","volume":"286","author":"RS D\u2019Agostino","year":"2001","unstructured":"D\u2019Agostino RS, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Jama-J Am Med Assoc. 2001;286:180\u20137.","journal-title":"Jama-J Am Med Assoc"},{"key":"2873_CR86","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DJ Goff","year":"2014","unstructured":"Goff DJ, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49-73.","journal-title":"Circulation"},{"key":"2873_CR87","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12933-023-01820-9","volume":"22","author":"Z Ye","year":"2023","unstructured":"Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, et al. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model. Cardiovasc Diabetol. 2023;22:87.","journal-title":"Cardiovasc Diabetol"},{"key":"2873_CR88","doi-asserted-by":"publisher","first-page":"e040254","DOI":"10.1161\/JAHA.124.040254","volume":"14","author":"TG Phan","year":"2025","unstructured":"Phan TG, Srikanth VK, Cadilhac DA, Nelson M, Kim J, Olaiya MT, et al. Framingham risk score prediction at 12 months in the STANDFIRM randomized control trial. J Am Heart Assoc. 2025;14:e040254.","journal-title":"J Am Heart Assoc"},{"key":"2873_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14232625","author":"ME Ozpelit","year":"2024","unstructured":"Ozpelit ME, Colak A, Uzumcu HI, Kumral Z, Ozpelit E. Correlation and agreement between the SCORE2 and PREVENT 10-year atherosclerotic cardiovascular disease risk scores: insights from coronary computed tomography angiography. Diagnostics. 2024. https:\/\/doi.org\/10.3390\/diagnostics14232625.","journal-title":"Diagnostics"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02873-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:43:50Z","timestamp":1757328230000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02873-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2873"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02873-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"306"}}